Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols.

Southern medical journal - 1 Feb 2005

Srinivas Dasarathy, Mani Haresh, Crumpler Charles C, Van Thiel David H

Abstract excerpt

OBJECTIVES: Up to 30% of the 5 million patients with chronic hepatitis C in the United States have normal serum alanine transaminase (ALT) levels. These individuals have not been treated aggressively, and reported response rates have been low. No study has targeted patients treated in a community practice setting. METHODS: Consecutive patients with chronic hepatitis C with normal or near-normal serum ALT levels...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Hepatitis C, Chronic

Share to Interferons

Share to Logistic Models

Share to Pilot Projects

Share to Treatment Outcome

Source

Identifiers

PMID: 15759946
DOI: 10.1097/01.SMJ.0000145303.01892.F0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols.PMID 15759946Read ↗

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.Semantic proximity Read ↗

Treatment of hepatitis C.Semantic proximity Read ↗

IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.Semantic proximity Read ↗

Therapy of hepatitis C: patients with normal aminotransferase levels.Semantic proximity Read ↗

Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT.Semantic proximity Read ↗

Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.Semantic proximity Read ↗

Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.Semantic proximity Read ↗

Alanine aminotransferase normalization at week 8 predicts viral response during hepatitis C treatment.Semantic proximity Read ↗

Current therapies for chronic hepatitis C. Drug combination achieves sustained response in more than half of patients.Semantic proximity Read ↗

Pegylated interferon alpha-2b in patients with acute hepatitis C.Semantic proximity Read ↗

Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study.Semantic proximity Read ↗

A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.